Journey Medical Corporation (DERM) — Business segments and KPIs
Revenue by business segment and geography for Journey Medical Corporation, with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Qbrexza | 25.01M | 66.0% |
| Accutane | 12.88M | 34.0% |